185 related articles for article (PubMed ID: 36638328)
21. The histone demethylase UTX/KDM6A in cancer: Progress and puzzles.
Schulz WA; Lang A; Koch J; Greife A
Int J Cancer; 2019 Aug; 145(3):614-620. PubMed ID: 30628063
[TBL] [Abstract][Full Text] [Related]
22. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
Yi J; Shi X; Xuan Z; Wu J
Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
[TBL] [Abstract][Full Text] [Related]
23. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
Yıldırım-Buharalıoğlu G
Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
[TBL] [Abstract][Full Text] [Related]
24. Implication of
Matar M; Prince G; Hamati I; Baalbaky M; Fares J; Aoude M; Matar C; Kourie HR
Pharmacogenomics; 2023 Jun; 24(9):509-522. PubMed ID: 37458596
[No Abstract] [Full Text] [Related]
25. Stat5a promotes brown adipocyte differentiation and thermogenic program through binding and transactivating the Kdm6a promoter.
Liu W; Ji Y; Zhang B; Chu H; Yin C; Xiao Y
Cell Cycle; 2020 Apr; 19(8):895-905. PubMed ID: 32207362
[TBL] [Abstract][Full Text] [Related]
26. KDM6A Regulates Cell Plasticity and Pancreatic Cancer Progression by Noncanonical Activin Pathway.
Yi Z; Wei S; Jin L; Jeyarajan S; Yang J; Gu Y; Kim HS; Schechter S; Lu S; Paulsen MT; Bedi K; Narayanan IV; Ljungman M; Crawford HC; Pasca di Magliano M; Ge K; Dou Y; Shi J
Cell Mol Gastroenterol Hepatol; 2022; 13(2):643-667. PubMed ID: 34583087
[TBL] [Abstract][Full Text] [Related]
27. KDM6A, a histone demethylase, regulates stress hematopoiesis and early B-cell differentiation.
Huppertz S; Senger K; Brown A; Leins H; Eiwen K; Mulaw MA; Geiger H; Becker M
Exp Hematol; 2021 Jul; 99():32-43.e13. PubMed ID: 34126175
[TBL] [Abstract][Full Text] [Related]
28. Histone demethylase KDM6A promotes somatic cell reprogramming by epigenetically regulating the PTEN and IL-6 signal pathways.
Jiang Q; Huang X; Hu X; Shan Z; Wu Y; Wu G; Lei L
Stem Cells; 2020 Aug; 38(8):960-972. PubMed ID: 32346926
[TBL] [Abstract][Full Text] [Related]
29. Intravesical delivery of
Kong N; Zhang R; Wu G; Sui X; Wang J; Kim NY; Blake S; De D; Xie T; Cao Y; Tao W
Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35131941
[TBL] [Abstract][Full Text] [Related]
30. KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress.
Soto DR; Barton C; Munger K; McLaughlin-Drubin ME
PLoS Pathog; 2017 Oct; 13(10):e1006661. PubMed ID: 28968467
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death.
Cottone L; Cribbs AP; Khandelwal G; Wells G; Ligammari L; Philpott M; Tumber A; Lombard P; Hookway ES; Szommer T; Johansson C; Brennan PE; Pillay N; Jenner RG; Oppermann U; Flanagan AM
Cancer Res; 2020 Oct; 80(20):4540-4551. PubMed ID: 32855205
[TBL] [Abstract][Full Text] [Related]
32. MiR-153-3p inhibits osteogenic differentiation of periodontal ligament stem cells through KDM6A-induced demethylation of H3K27me3.
Jiang H; Jia P
J Periodontal Res; 2021 Apr; 56(2):379-387. PubMed ID: 33368310
[TBL] [Abstract][Full Text] [Related]
33. Lysine-specific Demethylase 6A Upregulates Cadherin-1 and Accelerates Gastric Cancer Growth.
Li D; Zhang S; Yan Q; Li Y
Curr Pharm Biotechnol; 2023; 24(14):1827-1835. PubMed ID: 36941815
[TBL] [Abstract][Full Text] [Related]
34. KDM6A Depletion in Breast Epithelial Cells Leads to Reduced Sensitivity to Anticancer Agents and Increased TGFβ Activity.
Xiao JF; Kua LF; Ding LW; Sun QY; Myint KN; Chia XR; Venkatachalam N; Loh X; Duex JE; Neang V; Zhou S; Li Y; Yang H; Koeffler HP; Theodorescu D
Mol Cancer Res; 2022 Apr; 20(4):637-649. PubMed ID: 35022315
[TBL] [Abstract][Full Text] [Related]
35. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
DeGraff DJ; Clark PE; Cates JM; Yamashita H; Robinson VL; Yu X; Smolkin ME; Chang SS; Cookson MS; Herrick MK; Shariat SF; Steinberg GD; Frierson HF; Wu XR; Theodorescu D; Matusik RJ
PLoS One; 2012; 7(5):e36669. PubMed ID: 22590586
[TBL] [Abstract][Full Text] [Related]
36. [Research Advances in Lysine-specific Demethylase 6A and Its Application in Treating Leukemia].
Shen J; Zeng ZH; Yang L; Zeng MJ; Ouyang ZS; Zhao MY; Yang MH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):548-555. PubMed ID: 31484620
[TBL] [Abstract][Full Text] [Related]
37. KDM6A Lysine Demethylase Directs Epigenetic Polarity of MDSCs during Murine Sepsis.
Bah I; Alkhateeb T; Youssef D; Yao ZQ; McCall CE; El Gazzar M
J Innate Immun; 2022; 14(2):112-123. PubMed ID: 34289476
[TBL] [Abstract][Full Text] [Related]
38. The KDM6A-SPARCL1 axis blocks metastasis and regulates the tumour microenvironment of gastrointestinal stromal tumours by inhibiting the nuclear translocation of p65.
Shen C; Han L; Liu B; Zhang G; Cai Z; Yin X; Yin Y; Chen Z; Zhang B
Br J Cancer; 2022 Jun; 126(10):1457-1469. PubMed ID: 35136209
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.
Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR
Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507
[TBL] [Abstract][Full Text] [Related]
40. KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.
Boila LD; Ghosh S; Bandyopadhyay SK; Jin L; Murison A; Zeng AGX; Shaikh W; Bhowmik S; Muddineni SSNA; Biswas M; Sinha S; Chatterjee SS; Mbong N; Gan OI; Bose A; Chakraborty S; Arruda A; Kennedy JA; Mitchell A; Lechman ER; Banerjee D; Milyavsky M; Minden MD; Dick JE; Sengupta A
Leukemia; 2023 Apr; 37(4):751-764. PubMed ID: 36720973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
